4//SEC Filing
MERRIFIELD C ANN 4
Accession 0000950170-23-031866
CIK 0001327273other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 9:49 PM ET
Size
5.3 KB
Accession
0000950170-23-031866
Insider Transaction Report
Form 4
MERRIFIELD C ANN
Director
Transactions
- Award
Stock Option
2023-06-30+20,000→ 20,000 totalExercise: $4.11Exp: 2033-06-29→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable on June 30, 2024, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001247224
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 9:49 PM ET
- Size
- 5.3 KB